Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Gynecol Oncol. 2008 Apr 21;110(1):60–64. doi: 10.1016/j.ygyno.2008.02.011

Table 4.

Abdominal Discomfort Subscale Score

Assessment points No. IV Mean ± S.D. No. IV/IP Mean ± S.D. Difference Mean ± S.E.
Baseline (pre-randomization) 197 11.7 ± 3.5 195 11.0 ± 3.7 0.7 ± 0.36
Prior to cycle 4 173 14.0 ± 2.9 144 12.6 ± 3.3 1.4 ± 0.35
Change from baseline1 168 2.4 ± 3.65 139 1.5 ± 4.11 0.91 ±0.44

Note: Higher score indicates less abdominal discomfort.

1

Overall effect size for change in AD score from baseline to cycle 4 is 0.52 (pooled analysis of patients who provided baseline and cycle 4 responses). Patients in IV arm experienced significantly more improvement in AD from baseline to pre cycle 4 assessment. Baseline to cycle 4 change scores were significantly different between groups (p=.04). This difference diminished after treatment completion and no longer existed by one year follow up (ref JCO Feb 1, 2007).